Author correction to “Development of small-molecule tropomyosin receptor kinase (TRK) inhibitors for NTRK fusion cancers” [Acta Pharmaceutica Sinica B 11 (2021) 355–372]

Detalles Bibliográficos
Autores principales: Jiang, Tingting, Wang, Guan, Liu, Yao, Feng, Lu, Wang, Meng, Liu, Jie, Chen, Yi, Ouyang, Liang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Correction
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9214051/
https://www.ncbi.nlm.nih.gov/pubmed/35755289
http://dx.doi.org/10.1016/j.apsb.2022.02.028
_version_ 1784730940016164864
author Jiang, Tingting
Wang, Guan
Liu, Yao
Feng, Lu
Wang, Meng
Liu, Jie
Chen, Yi
Ouyang, Liang
author_facet Jiang, Tingting
Wang, Guan
Liu, Yao
Feng, Lu
Wang, Meng
Liu, Jie
Chen, Yi
Ouyang, Liang
author_sort Jiang, Tingting
collection PubMed
description
format Online
Article
Text
id pubmed-9214051
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-92140512022-06-23 Author correction to “Development of small-molecule tropomyosin receptor kinase (TRK) inhibitors for NTRK fusion cancers” [Acta Pharmaceutica Sinica B 11 (2021) 355–372] Jiang, Tingting Wang, Guan Liu, Yao Feng, Lu Wang, Meng Liu, Jie Chen, Yi Ouyang, Liang Acta Pharm Sin B Correction Elsevier 2022-06 2022-03-02 /pmc/articles/PMC9214051/ /pubmed/35755289 http://dx.doi.org/10.1016/j.apsb.2022.02.028 Text en © 2022 Chinese Pharmaceutical Association and Institute of Materia Medica, Chinese Academy of Medical Sciences. Production and hosting by Elsevier B.V. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Correction
Jiang, Tingting
Wang, Guan
Liu, Yao
Feng, Lu
Wang, Meng
Liu, Jie
Chen, Yi
Ouyang, Liang
Author correction to “Development of small-molecule tropomyosin receptor kinase (TRK) inhibitors for NTRK fusion cancers” [Acta Pharmaceutica Sinica B 11 (2021) 355–372]
title Author correction to “Development of small-molecule tropomyosin receptor kinase (TRK) inhibitors for NTRK fusion cancers” [Acta Pharmaceutica Sinica B 11 (2021) 355–372]
title_full Author correction to “Development of small-molecule tropomyosin receptor kinase (TRK) inhibitors for NTRK fusion cancers” [Acta Pharmaceutica Sinica B 11 (2021) 355–372]
title_fullStr Author correction to “Development of small-molecule tropomyosin receptor kinase (TRK) inhibitors for NTRK fusion cancers” [Acta Pharmaceutica Sinica B 11 (2021) 355–372]
title_full_unstemmed Author correction to “Development of small-molecule tropomyosin receptor kinase (TRK) inhibitors for NTRK fusion cancers” [Acta Pharmaceutica Sinica B 11 (2021) 355–372]
title_short Author correction to “Development of small-molecule tropomyosin receptor kinase (TRK) inhibitors for NTRK fusion cancers” [Acta Pharmaceutica Sinica B 11 (2021) 355–372]
title_sort author correction to “development of small-molecule tropomyosin receptor kinase (trk) inhibitors for ntrk fusion cancers” [acta pharmaceutica sinica b 11 (2021) 355–372]
topic Correction
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9214051/
https://www.ncbi.nlm.nih.gov/pubmed/35755289
http://dx.doi.org/10.1016/j.apsb.2022.02.028
work_keys_str_mv AT jiangtingting authorcorrectiontodevelopmentofsmallmoleculetropomyosinreceptorkinasetrkinhibitorsforntrkfusioncancersactapharmaceuticasinicab112021355372
AT wangguan authorcorrectiontodevelopmentofsmallmoleculetropomyosinreceptorkinasetrkinhibitorsforntrkfusioncancersactapharmaceuticasinicab112021355372
AT liuyao authorcorrectiontodevelopmentofsmallmoleculetropomyosinreceptorkinasetrkinhibitorsforntrkfusioncancersactapharmaceuticasinicab112021355372
AT fenglu authorcorrectiontodevelopmentofsmallmoleculetropomyosinreceptorkinasetrkinhibitorsforntrkfusioncancersactapharmaceuticasinicab112021355372
AT wangmeng authorcorrectiontodevelopmentofsmallmoleculetropomyosinreceptorkinasetrkinhibitorsforntrkfusioncancersactapharmaceuticasinicab112021355372
AT liujie authorcorrectiontodevelopmentofsmallmoleculetropomyosinreceptorkinasetrkinhibitorsforntrkfusioncancersactapharmaceuticasinicab112021355372
AT chenyi authorcorrectiontodevelopmentofsmallmoleculetropomyosinreceptorkinasetrkinhibitorsforntrkfusioncancersactapharmaceuticasinicab112021355372
AT ouyangliang authorcorrectiontodevelopmentofsmallmoleculetropomyosinreceptorkinasetrkinhibitorsforntrkfusioncancersactapharmaceuticasinicab112021355372

Ejemplares similares